In a study including 49 CLL patients, Liu et al. found that all CLL patients had markedly increased CD14+HLA-DRlow/− MDSCs, which lessen the CD4+ T-cell immunological response and promote CLL cell development [81]. The gene discussed is CD14; the disease is B-cell chronic lymphocytic leukemia.